Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?

J Am Coll Cardiol. 2016 Jun 28;67(25):3025. doi: 10.1016/j.jacc.2016.02.084.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticholesteremic Agents
  • Cardiovascular Diseases
  • Cholesterol, LDL
  • Drug Therapy, Combination
  • Ezetimibe*
  • Humans
  • Hypercholesterolemia
  • Secondary Prevention
  • Simvastatin*

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Simvastatin
  • Ezetimibe